Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,239
Onyx™ Liquid Embolic IDE Clinical Study
for
Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,
Location: Nashville TN, Columbus OH, Chapel Hill NC, Chicago IL,
Sponsor: Medtronic Endovascular
Sex: All
Age: 22+
Code: NCT06742801
Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: Nashville TN, Louisville KY, Atlanta GA, Memphis TN,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase 3, Recruiting
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Nashville TN, Birmingham AL, Atlanta GA, Cincinnati OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase 3, Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Location: Nashville TN, Atlanta GA, St Louis MO, Charlotte NC,
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 0+
Code: NCT03394365
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
for
Relapsed or Refractory Large B-cell Lymphoma
Location: Nashville TN, Newnan GA, St Louis MO, Charlotte NC,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18+
Code: NCT07479797
Phase 3, Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Nashville TN, Knoxville TN, Birmingham AL, Atlanta GA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase 3, Recruiting
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
for
Metastatic Castration-Resistant Prostate Cancer
Location: Nashville TN, Atlanta GA, Durham NC, Myrtle Beach SC,
Sponsor: Kyntra Bio
Sex: Male
Age: 18+
Code: NCT06842498
Phase 2, Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers
for
Diabetic Foot Ulcer
Location: Nashville TN, O'Fallon IL, Augusta GA, Columbus OH,
Sponsor: Piomic Medical
Sex: All
Age: 22 - 70+
Code: NCT05758545
Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: Nashville TN, Louisville KY, Atlanta GA, Wytheville VA,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05253651
Phase 3, Recruiting
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
for
Sensorineural Hearing Loss, Bilateral
Location: Nashville TN, Iowa City IA, San Francisco CA
Sponsor: Eli Lilly and Company
Sex: All
Age: 0+
Code: NCT05821959
Phase 3, Recruiting
Clinical Outcomes of the ALPS Proximal Humerus Plating System
for
Proximal Humeral Fracture
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18+
Code: NCT03328650
Recruiting
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
for
Marginal Zone Lymphoma
Location: Nashvile TN, Atlanta GA, Miami FL, Duarte CA
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT05296070
Phase 2, Recruiting
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors